The prognostic effects of somatic mutations in ER-positive breast cancer

被引：98

作者：

Griffith, Obi L. ^{[1
,2
,3
,4
]}

Spies, Nicholas C. ^{[1
]}

Anurag, Meenakshi ^{[5
,6
,7
,8
]}

Griffith, Malachi ^{[1
,2
,3
,4
]}

Luo, Jingqin ^{[3
,9
]}

Tu, Dongsheng ^{[10
]}

Yeo, Belinda ^{[11
]}

Kunisaki, Jason ^{[1
]}

Miller, Christopher A. ^{[1
,2
]}

Krysiak, Kilannin ^{[1
,2
]}

Hundal, Jasreet ^{[1
]}

Ainscough, Benjamin J. ^{[1
]}

Skidmore, Zachary L. ^{[1
]}

Campbell, Katie ^{[1
]}

Kumar, Runjun ^{[2
]}

Fronick, Catrina ^{[1
]}

Cook, Lisa ^{[1
]}

Snider, Jacqueline E. ^{[2
]}

Davies, Sherri ^{[2
]}

Kavuri, Shyam M. ^{[5
,6
,7
,8
]}

Chang, Eric C. ^{[5
,6
,7
,8
]}

Magrini, Vincent ^{[1
,4
,12
,13
]}

Larson, David E. ^{[1
]}

Fulton, Robert S. ^{[1
,4
]}

Liu, Shuzhen ^{[10
]}

Leung, Samuel ^{[10
]}

Voduc, David ^{[10
]}

Bose, Ron ^{[2
]}

Dowsett, Mitch ^{[11
]}

Wilson, Richard K. ^{[1
,3
,4
]}

Nielsen, Torsten O. ^{[10
]}

Mardis, Elaine R. ^{[1
,3
,4
,12
,13
]}

Ellis, Matthew J. ^{[5
,6
,7
,8
]}

机构：

[1] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63108 USA

[2] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA

[3] Washington Univ, Sch Med, St Louis, MO 63110 USA

[4] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA

[5] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA

[6] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA

[7] Baylor Coll Med, Dept Med, Houston, TX 77030 USA

[8] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA

[9] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA

[10] Univ British Columbia, Genet Pathol Evaluat Ctr, Vancouver, BC V6H 3Z6, Canada

[11] Inst Canc Res, London SM2 5NG, England

[12] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Columbus, OH 43205 USA

[13] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43205 USA

来源：

NATURE COMMUNICATIONS | 2018年 / 9卷

关键词：

ACUTE MYELOID-LEUKEMIA; FALSE DISCOVERY RATES; POSTMENOPAUSAL WOMEN; LUNG ADENOCARCINOMA; SEQUENCE-ANALYSIS; HER2; MUTATIONS; PD-1; BLOCKADE; TAMOXIFEN; VARIANTS; GENOME;

D O I：

10.1038/s41467-018-05914-x

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Here we report targeted sequencing of 83 genes using DNA from primary breast cancer samples from 625 postmenopausal (UBC-TAM series) and 328 premenopausal (MA12 trial) hormone receptor-positive (HR+) patients to determine interactions between somatic mutation and prognosis. Independent validation of prognostic interactions was achieved using data from the METABRIC study. Previously established associations between MAP3K1 and PIK3CA mutations with luminal A status/favorable prognosis and TP53 mutations with Luminal B/non-luminal tumors/poor prognosis were observed, validating the methodological approach. In UBC-TAM, NF1 frame-shift nonsense (FS/NS) mutations were also a poor outcome driver that was validated in METABRIC. For MA12, poor outcome associated with PIK3R1 mutation was also reproducible. DDR1 mutations were strongly associated with poor prognosis in UBC-TAM despite stringent false discovery correction (q = 0.0003). In conclusion, uncommon recurrent somatic mutations should be further explored to create a more complete explanation of the highly variable outcomes that typifies ER+ breast cancer.

引用

页数：16

共 58 条

[1] DoCM: a database of curated mutations in cancer
Ainscough, Benjamin J.
Griffith, Malachi
Coffman, Adam C.
Wagner, Alex H.
Kunisaki, Jason
Choudhary, Mayank N. K.
McMichael, Joshua F.
Fulton, Robert S.
Wilson, Richard K.
Griffith, Obi L.
Mardis, Elaine R.
[J]. NATURE METHODS, 2016, 13 (10) : 806 - 807
[2] A map of human genome variation from population-scale sequencing
Altshuler, David
Durbin, Richard M.
Abecasis, Goncalo R.
Bentley, David R.
Chakravarti, Aravinda
Clark, Andrew G.
Collins, Francis S.
De la Vega, Francisco M.
Donnelly, Peter
Egholm, Michael
Flicek, Paul
Gabriel, Stacey B.
Gibbs, Richard A.
Knoppers, Bartha M.
Lander, Eric S.
Lehrach, Hans
Mardis, Elaine R.
McVean, Gil A.
Nickerson, DebbieA.
Peltonen, Leena
Schafer, Alan J.
Sherry, Stephen T.
Wang, Jun
Wilson, Richard K.
Gibbs, Richard A.
Deiros, David
Metzker, Mike
Muzny, Donna
Reid, Jeff
Wheeler, David
Wang, Jun
Li, Jingxiang
Jian, Min
Li, Guoqing
Li, Ruiqiang
Liang, Huiqing
Tian, Geng
Wang, Bo
Wang, Jian
Wang, Wei
Yang, Huanming
Zhang, Xiuqing
Zheng, Huisong
Lander, Eric S.
Altshuler, David L.
Ambrogio, Lauren
Bloom, Toby
Cibulskis, Kristian
Fennell, Tim J.
Gabriel, Stacey B.
[J]. NATURE, 2010, 467 (7319) : 1061 - 1073
[3] Extracting replicable associations across multiple studies: Empirical Bayes algorithms for controlling the false discovery rate
Amar, David
Shamir, Ron
Yekutieli, Daniel
[J]. PLOS COMPUTATIONAL BIOLOGY, 2017, 13 (08) : e1005700
[4] Sequence analysis of mutations and translocations across breast cancer subtypes
Banerji, Shantanu
Cibulskis, Kristian
Rangel-Escareno, Claudia
Brown, Kristin K.
Carter, Scott L.
Frederick, Abbie M.
Lawrence, Michael S.
Sivachenko, Andrey Y.
Sougnez, Carrie
Zou, Lihua
Cortes, Maria L.
Fernandez-Lopez, Juan C.
Peng, Shouyong
Ardlie, Kristin G.
Auclair, Daniel
Bautista-Pina, Veronica
Duke, Fujiko
Francis, Joshua
Jung, Joonil
Maffuz-Aziz, Antonio
Onofrio, Robert C.
Parkin, Melissa
Pho, Nam H.
Quintanar-Jurado, Valeria
Ramos, Alex H.
Rebollar-Vega, Rosa
Rodriguez-Cuevas, Sergio
Romero-Cordoba, Sandra L.
Schumacher, Steven E.
Stransky, Nicolas
Thompson, Kristin M.
Uribe-Figueroa, Laura
Baselga, Jose
Beroukhim, Rameen
Polyak, Kornelia
Sgroi, Dennis C.
Richardson, Andrea L.
Jimenez-Sanchez, Gerardo
Lander, Eric S.
Gabriel, Stacey B.
Garraway, Levi A.
Golub, Todd R.
Melendez-Zajgla, Jorge
Toker, Alex
Getz, Gad
Hidalgo-Miranda, Alfredo
Meyerson, Matthew
[J]. NATURE, 2012, 486 (7403) : 405 - 409
[5] Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
Bose, Ron
Kavuri, Shyam M.
Searleman, Adam C.
Shen, Wei
Shen, Dong
Koboldt, Daniel C.
Monsey, John
Goel, Nicholas
Aronson, Adam B.
Li, Shunqiang
Ma, Cynthia X.
Ding, Li
Mardis, Elaine R.
Ellis, Matthew J.
[J]. CANCER DISCOVERY, 2013, 3 (02) : 224 - 237
[6] A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada-Clinical Trials Group Trial, MA.12)
Bramwell, V. H. C.
Pritchard, K. I.
Tu, D.
Tonkin, K.
Vachhrajani, H.
Vandenberg, T. A.
Robert, J.
Arnold, A.
O'Reilly, S. E.
Graham, B.
Shepherd, L.
[J]. ANNALS OF ONCOLOGY, 2010, 21 (02) : 283 - 290
[7] False Discovery Rates for Rare Variants From Sequenced Data
Capanu, Marinela
Seshan, Venkatraman E.
[J]. GENETIC EPIDEMIOLOGY, 2015, 39 (02) : 65 - 76
[8] Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas
Chanock, Stephen J.
Burdett, Laurie
Yeager, Meredith
Llaca, Victor
Langerod, Anita
Presswalla, Shafaq
Kaaresen, Rolf
Strausberg, Robert L.
Gerhard, Daniela S.
Kristensen, Vessela
Perou, Charles M.
Borresen-Dale, Anne-Lise
[J]. BREAST CANCER RESEARCH, 2007, 9 (01)
[9] Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Cheang, Maggie C. U.
Chia, Stephen K.
Voduc, David
Gao, Dongxia
Leung, Samuel
Snider, Jacqueline
Watson, Mark
Davies, Sherri
Bernard, Philip S.
Parker, Joel S.
Perou, Charles M.
Ellis, Matthew J.
Nielsen, Torsten O.
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (10): : 736 - 750
[10] A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen
Chia, Stephen K.
Bramwell, Vivien H.
Tu, Dongsheng
Shepherd, Lois E.
Jiang, Shan
Vickery, Tammi
Mardis, Elaine
Leung, Samuel
Ung, Karen
Pritchard, Kathleen I.
Parker, Joel S.
Bernard, Philip S.
Perou, Charles M.
Ellis, Matthew J.
Nielsen, Torsten O.
[J]. CLINICAL CANCER RESEARCH, 2012, 18 (16) : 4465 - 4472

← 1 2 3 4 5 6 →